Previous section Next section
PATHWAY OF GLYCOGENOLYSIS IN LIVER
Body_ID: HC012004
As with most metabolic pathways, separate enzymes, sometimes in separate subcellular compartments, are required for the forward and reverse pathways. The pathway of glycogenolysis (Fig. 12.3B) begins with removal of the abundant, external α1→4 -linked glucoseView drug information residues in glycogen. This is accomplished not by a hydrolase, but by glycogen phosphorylase, an enzyme that uses cytosolic phosphate and releases glucoseView drug information from glycogen in the form of Glc-1-P, which is converted into Glc-6-P by phosphoglucomutase. In liver the glucoseView drug information is released from Glc-6-P by glucose-6-phosphatase (Glc-6-Pase), and the glucoseView drug information exits via the GLUT-2 transporter into blood. The rate-limiting, regulatory step in glycogenolysis is catalyzed by phosphorylase, the first enzyme in the pathway.
Body_ID: P012014
page 159
0
page 160
Body_ID: P0160
Body_ID: T012002
Table 12-2. Hormones involved in control of glycogenolysis.
Body_ID: None
Hormonal control of glycogenolysis
Body_ID: T012002.50
HormoneSourceInitiatorEffect on glycogenolysis
Body_ID: T012002.100
glucagonpancreatic α-cellshypoglycemiarapid activation
Body_ID: T012002.150
epinephrineView drug informationadrenal medullaacute stress, hypoglycemiarapid activation
Body_ID: T012002.200
cortisoladrenal cortexchronic stresschronic activation
Body_ID: T012002.250
insulinpancreatic β-cellshyperglycemiainhibition
Body_ID: T012002.300
Body_ID: T012002
Body_ID: None
Phosphorylase is specific for α1→4 glycosidic linkages; it cannot cleave α1→6 linkages. Further, this enzyme cannot approach the branching glucoseView drug information residues efficiently. Thus, as shown in Figure 12.3B, phosphorylase cleaves the external glucoseView drug information residues until the branches are three or four residues long, then debranching enzyme, which has both transglycosylase and glucosidase activity, moves a short segment of glucoseView drug information residues bound to the α1→6 branch to the end of an adjacent α1→4 chain, leaving a single glucoseView drug information residue at the branch point. This glucoseView drug information is then removed by the exo-1,6-glucosidase activity of branching enzyme, allowing glycogen phosphorylase to proceed with degradation of the α1→4 chain until another branch point is approached, setting the stage for a repeat of the transglycosylase and glucosidase reactions. About 90% of the glucoseView drug information is released from glycogen as Glc-1-P, and the remainder, derived from the α1→6 branching residues, as free glucoseView drug information.
Body_ID: P012015
Previous section
Bar end Bar end
Next section
Copyright © 2007 Elsevier Inc. All rights reserved. Read our Terms and Conditions of Use and our Privacy Policy.
For problems or suggestions concerning this service, please contact: studentconsult.help@elsevier.com